P Roy Vagelos - Net Worth and Insider Trading
P Roy Vagelos Net Worth
The estimated net worth of P Roy Vagelos is at least $416 Million dollars as of 2024-11-10. P Roy Vagelos is the Director of Regeneron Pharmaceuticals Inc and owns about 501,738 shares of Regeneron Pharmaceuticals Inc (REGN) stock worth over $416 Million. Details can be seen in P Roy Vagelos's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that P Roy Vagelos has not made any transactions after 2022-03-30 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of P Roy Vagelos
P Roy Vagelos Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, P Roy Vagelos owns 2 companies in total, including Regeneron Pharmaceuticals Inc (REGN) , and Innoviva Inc (INVA) .
Click here to see the complete history of P Roy Vagelos’s form 4 insider trades.
Insider Ownership Summary of P Roy Vagelos
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| REGN | Regeneron Pharmaceuticals Inc | 2022-03-30 | director |
| INVA | Innoviva Inc | 2004-10-04 | director |
P Roy Vagelos Latest Holdings Summary
P Roy Vagelos currently owns a total of 1 stock. P Roy Vagelos owns 501,738 shares of Regeneron Pharmaceuticals Inc (REGN) as of March 30, 2022, with a value of $416 Million.
Latest Holdings of P Roy Vagelos
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| REGN | Regeneron Pharmaceuticals Inc | 2022-03-30 | 501,738 | 828.42 | 415,649,794 |
Holding Weightings of P Roy Vagelos
P Roy Vagelos Form 4 Trading Tracker
According to the SEC Form 4 filings, P Roy Vagelos has made a total of 7 transactions in Regeneron Pharmaceuticals Inc (REGN) over the past 5 years, including 0 buys and 7 sells. The most-recent trade in Regeneron Pharmaceuticals Inc is the sale of 28,572 shares on March 30, 2022, which brought P Roy Vagelos around $20 Million.
Insider Trading History of P Roy Vagelos
- 1
P Roy Vagelos Trading Performance
P Roy Vagelos Ownership Network
Ownership Network List of P Roy Vagelos
Ownership Network Relation of P Roy Vagelos
P Roy Vagelos Owned Company Details
What does Regeneron Pharmaceuticals Inc do?
Who are the key executives at Regeneron Pharmaceuticals Inc?
P Roy Vagelos is the director of Regeneron Pharmaceuticals Inc. Other key executives at Regeneron Pharmaceuticals Inc include SVP Commercial Marion Mccourt , VP & Controller Christopher R. Fenimore , and EVP Research Andrew J Murphy .
Regeneron Pharmaceuticals Inc (REGN) Insider Trades Summary
Over the past 18 months, P Roy Vagelos made no insider transaction in Regeneron Pharmaceuticals Inc (REGN). Other recent insider transactions involving Regeneron Pharmaceuticals Inc (REGN) include a net sale of 10,814 shares made by Marion Mccourt , a net sale of 1,400 shares made by Arthur F Ryan , and a net sale of 7,918 shares made by Bonnie L Bassler .
In summary, during the past 3 months, insiders sold 26,837 shares of Regeneron Pharmaceuticals Inc (REGN) in total and bought 0 shares, with a net sale of 26,837 shares. During the past 18 months, 315,919 shares of Regeneron Pharmaceuticals Inc (REGN) were sold and 0 shares were bought by its insiders, resulting in a net sale of 315,919 shares.
Regeneron Pharmaceuticals Inc (REGN)'s detailed insider trading history can be found in Insider Trading Tracker table.
Regeneron Pharmaceuticals Inc Insider Transactions
P Roy Vagelos Mailing Address
Above is the net worth, insider trading, and ownership report for P Roy Vagelos. Currently GuruFocus does not have mailing address information for P Roy Vagelos.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
